fda bpc 157 category 2 compounding Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- to the 503A Bulks List for use in compounding for Is BPC-157 Legal in 2026?
Is BPC 157 Legal in 2026? FDA Compounding Status Explained Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy BPC 157 is shifting off FDA Category 2 ahead of the July 23 PCAC vote, with RFK Jr. pushing expanded compounding access. The mechanism centers on its role in upregulating growth factors and FDA Peptide Regulation Update: Compounding Pathways and Future Directions Katherine Erickson posted on the topic LinkedIn Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Peptide Review 2026: What This Big Shift Means
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



